Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001.
about
Epidemiology of hepatitis C in Croatia in the European contextAnalysis of duration of risk behaviour for key populations: a literature reviewEstimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progressionHepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco.High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs.Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities.Cross sectional study of factors associated to self-reported blood-borne infections among drug users.Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areasFull participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.Management of chronic hepatitis C: consensus guidelines.Epidemiology of hepatitis C virus infection in HIV-infected individuals.Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: a pilot study.Prevalence and correlates of needle-sharing among new and long-term injection drug users in southwest China.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies.HIV-1 and Hepatitis C virus selection bottleneck in Chinese people who inject drugs.Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program.
P2860
Q26795602-A5DA6E49-8743-4A0B-9158-055117DB3AEBQ27011344-745B7E4B-9FA7-4B74-83E0-38C5DB401DAAQ27485372-5831BFC0-4462-44C8-86E7-C478DDD4A40EQ27488500-53FFC8AA-39DF-45E9-9303-C18AEE6CFCE1Q30226766-E15A9F86-1181-46DF-87CE-7F3F185C4C11Q34079048-89D7B9D1-7E02-45C7-93FB-F7F479683E26Q34260555-F74DF1B3-01B9-4644-B908-CC12795D44AAQ35841089-1A91CA27-6592-437D-BC00-76415FC7DACAQ35962535-DD22384E-49E7-473F-A7FB-518E2D888532Q36088744-AA8F0295-7B87-4030-BC21-0D8871235787Q36849347-8A5A0A11-1999-4DD0-8382-FFF16E05A648Q37147214-22473099-92E3-4B92-AEC7-7ACB50518CBCQ39895599-C3D8E10D-BAB4-495D-9A74-873D5E78D018Q42663450-6F98DD87-3C6A-4C35-8352-AB656DD59A7FQ42720607-84337688-12B9-4265-9863-54EE0F956387Q42984463-707CBD61-CAF7-4F8C-907C-582C349F1F82Q45323939-E8D84398-3684-412E-97D6-1273D0F9FC53Q45370954-9B5446BA-8E54-4D66-B071-B895B24DE087
P2860
Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Significant reductions of HIV ...... opolitan Barcelona: 1987-2001.
@en
type
label
Significant reductions of HIV ...... opolitan Barcelona: 1987-2001.
@en
prefLabel
Significant reductions of HIV ...... opolitan Barcelona: 1987-2001.
@en
P2093
P50
P1476
Significant reductions of HIV ...... ropolitan Barcelona: 1987-2001
@en
P2093
Alvaro Muñoz
Celestino Rey-Joly
Cristina Tural
Ferran Bolao
Javier Santesmases
Ramon Pujol
P304
P356
10.1016/S0376-8716(06)80005-0
P478
82 Suppl 1
P577
2006-04-01T00:00:00Z